These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Treatment of severe bleeding in hemophilia A with factor VIII inhibitor. Mahasandana C; Suvatte V; Tanphaichitr VS; Bejrachandra S; Chandanayingyong D J Med Assoc Thai; 1988 Mar; 71(3):154-8. PubMed ID: 3133440 [No Abstract] [Full Text] [Related]
11. Immunoblot cross-reactivity of factor VIII inhibitors with porcine factor VIII. Koshihara K; Qian J; Lollar P; Hoyer LW Blood; 1995 Sep; 86(6):2183-90. PubMed ID: 7662967 [TBL] [Abstract][Full Text] [Related]
12. Complications of hemophilia A treatment: factor VIII inhibitors. Kasper CK Ann N Y Acad Sci; 1991; 614():97-105. PubMed ID: 1902643 [No Abstract] [Full Text] [Related]
13. Anti-factor VIII antibodies (Inhibitors) in hemophilia A: in dire need of basic and therapeutic research. Kaveri SV Clin Rev Allergy Immunol; 2009 Oct; 37(2):55-7. PubMed ID: 19153680 [No Abstract] [Full Text] [Related]
14. Inhibitor to factor VIII in mild haemophilia. Kesteven PJ; Holland LJ; Lawrie AS; Savidge GF Thromb Haemost; 1984 Aug; 52(1):50-2. PubMed ID: 6437010 [TBL] [Abstract][Full Text] [Related]
16. Immunochemical characterization of factor VIII inhibitors. Hoyer LW; Gawryl MS; de la Fuente B Prog Clin Biol Res; 1984; 150():73-85. PubMed ID: 6431443 [TBL] [Abstract][Full Text] [Related]
17. In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic. Scandella DH; Nakai H; Felch M; Mondorf W; Scharrer I; Hoyer LW; Saenko EL Thromb Res; 2001 Mar; 101(5):377-85. PubMed ID: 11297754 [TBL] [Abstract][Full Text] [Related]
18. Antibodies with hydrolytic activity towards factor VIII in patients with hemophilia A. Lacroix-Desmazes S; Misra N; Bayry J; Villard S; Kazatchkine MD; Kaveri SV J Immunol Methods; 2002 Nov; 269(1-2):251-6. PubMed ID: 12379365 [TBL] [Abstract][Full Text] [Related]
19. Adsorption of immunoglobulin G and anti-factor VIII inhibitory antibody from haemophiliac plasma to derivatized polystyrenes. Cornelius RM; Dahri L; Boisson-Vidal C; Muller D; Jozefonvicz J; Brash JL Biomaterials; 1997 Mar; 18(5):429-36. PubMed ID: 9061184 [TBL] [Abstract][Full Text] [Related]
20. Factor VIII inhibitor assay using plasma F VIII versus recombinant F VIII--a comparative study. Hillman-Wiseman C; Vitale C; Lusher J Thromb Res; 1994 Oct; 76(2):221-4. PubMed ID: 7863471 [No Abstract] [Full Text] [Related] [Next] [New Search]